Abstract 25P
Background
Breast cancer is the second most common cancer worldwide. Some studies have begun investigation of Absolute Lymphocyte Count (ALC) to predict prognosis of breast metastasis. This review aims to analyze use of ALC to predict overall survival (OS) in breast metastasis patients.
Methods
A total of 73,233 literatures were found through PubMed, PMC, Science Direct, and Google Scholar using a combination of keywords including ALC, breast metastasis, and OS. Publications included are limited to English manuscripts published within the last ten years. We excluded publications with insufficient datas and non-breast metastatic studies. Studies were evaluated by all four authors using the Newcastle-Ottawa Scale (NOS), JADAD scale, funnel plot to assess publication bias, and Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) to assess quality of this review.
Results
A total of 11 studies consisting 2,433 patients were included in this review. Nine retrospective studies were of good quality using NOS, two clinical trial studies were of low quality using JADAD scale. GRADE assessment revealed this review to be moderate in quality and publication biases are minimal. Most studies revealed an association between low ALC or lymphopenia and worse prognosis, while 1 study showed otherwise. A pooled analysis of hazard ratio (HR) from log-rank test (HR = 0.57; 95% CI, 0.46-0.71; P = 0.52), univariate cox regression analysis (HR = 0.69; 95%CI, 0.61-0.78; P = 0.01) and multivariate cox regression analysis (HR = 0.70; 95%CI, 0.60-0.81; P = 0.30) showed minimal correlation.
Conclusions
While most studies used in this review showed strong correlation between low ALC and OS with statistically significant results, pooled analysis from this review revealed only the univariate cox regression analysis of HR showed statistically significant results. We conclude that lymphopenia may affect OS in patients with metastatic breast cancer. Further studies are required, especially high quality clinical trials.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
6P - Deep learning radiomics supports perioperative treatment decisions and is associated with LncRNAs in breast cancer: A multicenter study
Presenter: Yunfang Yu
Session: Poster viewing 01
7P - Predicting lymph node metastasis and molecular subtype from pathology united with genomics in breast cancer with multitask deep learning
Presenter: Zehua Wang
Session: Poster viewing 01
8P - Dismantling the role of liquid biopsy in predicting outcome of patients with early-stage breast cancer following neoadjuvant therapy: A systematic review
Presenter: Jeremiah Wijaya
Session: Poster viewing 01
9P - Development and validation of a pathogenomics model to improve the risk stratification of breast cancer: A deep learning study
Presenter: lin ruichong
Session: Poster viewing 01
10P - Enriched gut microbiota increases anticancer drug efficacy in breast cancer cell lines: A promising in vitro approach
Presenter: Selvaraj Jayaraman
Session: Poster viewing 01
11P - Preservation of intercostobrachial nerve during axillary lymph node dissection in breast cancer patients positively impacts chronic pain, sensory changes, and quality of life: Should it be the standard?
Presenter: Ajai Sasidhar
Session: Poster viewing 01
12P - Non-clinical factors influencing patient’s choice of mastectomy over breast conservation among Indian women with breast cancer
Presenter: Nivedita Sharma
Session: Poster viewing 01
13P - Hypofractionated radiotherapy in post operative breast cancer patients: 3-year clinical experience in a newly established cancer center
Presenter: Shaila Sharmin
Session: Poster viewing 01
14P - The impact of the deep inspiration breath-hold (DIBH) technique in the heart and other organ-at-risk (OAR) dose sparing in the postoperative radiotherapy to the left early breast cancer
Presenter: Hui-Ling Yeh
Session: Poster viewing 01
15P - Delays in breast cancer treatment in a tertiary hospital
Presenter: Rogelio Velasco
Session: Poster viewing 01